Essam Abadir

Managing Partner at Aspire Ventures Precision Medicine Fund · Lancaster, United States

Invests in AI

Essam Abadir's investor profile lists AI alongside Healthcare & Biotech and IoT & Connected Devices, at pre-seed, seed, Series A and Series B. The record holds 2 deals, among them Wylei and Medstatix.

Email Investor

Email Investor

Credits to line up before a pre-seed round

Essam Abadir backs companies at pre-seed, seed and Series A. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Wylei
  • Medstatix

Investment focus

Backs startups in
Artificial Intelligence, Healthcare & Biotech, IoT & Connected Devices
Rounds
Pre-seed, Seed, Series A, Series B, Late-stage venture
Profile
Angel investor
Deals on record
2
Based in
Lancaster, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Essam Abadir invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Essam Abadir's investor profile, together with Healthcare & Biotech and IoT & Connected Devices. The stages on record are pre-seed, seed, Series A and Series B.
Which companies has Essam Abadir backed?
The record lists 2 deals, including Wylei and Medstatix. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Essam Abadir?
For a company raising a pre-seed round, AI Perks lists credits such as WordPress VIP (up to $20,000), DigitalOcean (up to $100,000), Oracle (up to $10,000) and Amazon Bedrock (up to $200,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor